January 2012, 12:30,
Open Access This content is freely available online to anyone, anywhere at any time.
Date: 20 Jan 2012
Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review
The role of human papillomavirus (HPV) in malignant and non-malignant genital diseases in women is well known and the corresponding epidemiological burden has been widely described. However, less is known about the role of HPV in anal, penile and head and neck cancer, and the burden of malignant and non-malignant HPV-related diseases in men. The objective of this review is to estimate the epidemiological burden of HPV-related cancers and non-malignant diseases in men in Europe.
The annual number of new HPV-related cancers in men in Europe was estimated using Eurostat population data and applying cancer incidence rates published by the International Agency for Research on Cancer. The number of cancer cases attributable to HPV, and specifically to HPV16/18, was calculated based on the most relevant prevalence estimates. The annual number of new cases of genital warts was calculated from the most robust European studies; and latest HPV6/11 prevalence estimates were then applied. A literature review was also performed to retrieve exhaustive data on HPV infection at all anatomical sites under study, as well as incidence and prevalence of external genital warts, recurrent respiratory papillomatosis and HPV-related cancer trends in men in Europe.
A total of 72, 694 new cancer cases at HPV-related anatomical sites were estimated to occur each year in men in Europe. 17,403 of these cancer cases could be attributable to HPV, with 15,497 of them specifically attributable to HPV16/18. In addition, between 286,682 and 325,722 new cases of genital warts attributable to HPV6/11were estimated to occur annually in men in Europe.
The overall estimated epidemiological burden of HPV-related cancers and non-malignant diseases is high in men in Europe. Approximately 30% of all new cancer cases attributable to HPV16/18 that occur yearly in Europe were estimated to occur in men. As in women, the vast majority of HPV-positive cancer in men is related to HPV16/18, while almost all HPV-related non-malignant diseases are due to HPV6/11. A substantial number of these malignant and non-malignant diseases may potentially be prevented by quadrivalent HPV vaccination.
HPV and cervical cancer in the 2007 report Vaccine 2007, 25 Suppl 3:C1–230. C1–230 C1-230
Roteli-Martins CM, de Carvalho NS, Naud P, Teixeira J, Borba P, Derchain S, et al.: Prevalence of human papillomavirus infection and associated risk factors in young women in Brazil, Canada, and the United States: a multicenter cross-sectional study. Int J Gynecol Pathol 2011, 30:173–184.PubMedCrossRef
Human papillomaviruses IARC Monogr Eval Carcinog Risks Hum 2007, 90:1–636. 1–636 1-636
Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Jeanue M, Boyle P: Comparability and quality of data. In Cancer Incidence in Five Containents. [http://www.iarc.fr/en/publications/pdfs-online/epi/sp160/CI5vol9–5.pdf] 2007.,9(Chapter 5):
Desai S, Wetten S, Woodhall SC, Peters L, Hughes G, Soldan K: Genital warts and cost of care in England. Sex Transm Infect 2011.
De VH, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S: Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009, 124:1626–1636.CrossRef
Nielsen A, Munk C, Kjaer SK: Trends in incidence of anal cancer and high-grade anal intraepithelial neoplasia in Denmark, 1978–2008. Int J Cancer 2011, 10.
Goldman S, Glimelius B, Nilsson B, Pahlman L: Incidence of anal epidermoid carcinoma in Sweden 1970–1984. Acta Chir Scand 1989, 155:191–197.PubMed
Van Lieshout A, Pronk A: [Increasing incidence of anal cancer in the Netherlands]. Ned Tijdschr Geneeskd 2010, 154:A1163.PubMed
Simms I, Fairley CK: Epidemiology of genital warts in England and Wales: 1971 to 1994. Genitourin Med 1997, 73:365–367.PubMed
Van Doornum GJ, Prins M, Juffermans LH, Hooykaas C, van den Hoek JA, Coutinho RA, et al.: Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study. Genitourin Med 1994, 70:240–246.PubMed
Piketty C, Darragh TM, Da CM, Bruneval P, Heard I, Kazatchkine MD, et al.: High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med 2003, 138:453–459.PubMed
Bleeker MC, Hogewoning CJ, Berkhof J, Voorhorst FJ, Hesselink AT, van Diemen PM, et al.: Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads. Clin Infect Dis 2005, 41:612–620.PubMedCrossRef
Wikstrom A, Lidbrink P, Johansson B, von KG: Penile human papillomavirus carriage among men attending Swedish STD clinics. Int J STD AIDS 1991, 2:105–109.PubMed
Forslund O, Hansson BG, Rymark P, Bjerre B: Human papillomavirus DNA in urine samples compared with that in simultaneously collected urethra and cervix samples. J Clin Microbiol 1993, 31:1975–1979.PubMed
Hillman RJ, Ryait BK, Botcherby M, Taylor-Robinson D: Human papillomavirus DNA in the urogenital tracts of men with gonorrhoea, penile warts or genital dermatoses. Genitourin Med 1993, 69:187–192.PubMed
Strand A, Rylander E, Evander M, Wadell G: Genital human papillomavirus infection among patients attending an STD clinic. Genitourin Med 1993, 69:446–449.PubMed
Lacey CJ, Lowndes CM, Shah KV: Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006, 24 Suppl 3:S3/35–41. S3–35-S3/41
Ramqvist T, Dalianis T: An epidemic of oropharyngeal squamous cell carcinoma (OSCC) due to human papillomavirus (HPV) infection and aspects of treatment and prevention. Anticancer Res 2011, 31:1515–1519.PubMed
Attner P, Du J, Nasman A, Hammarstedt L, Ramqvist T, Lindholm J, et al.: The role of human papillomavirus in the increased incidence of base of tongue cancer. Int J Cancer 2010, 126:2879–2884.PubMed
Colon-Lopez V, Ortiz AP, Palefsky J: Burden of human papillomavirus infection and related comorbidities in men: implications for research, disease prevention and health promotion among Hispanic men. P R Health Sci J 2010, 29:232–240.PubMed
Parkin DM, Bray F: Chapter 2: The burden of HPV-related cancers. Vaccine 2006, 24 Suppl 3:S3/11–25. S3- 11-S3/25
Kreimer AR, Bhatia RK, Messeguer AL, Gonzalez P, Herrero R, Giuliano AR: Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis 2010, 37:386–391.PubMed
Kreimer AR, Villa A, Nyitray A, Abrahamsen ME, Papenfuss MR, Smith D, et al.: The epidemiology of oral HPV infection among a multinational sample of healthy men. Cancer Epidemiol Biomarkers Prev 2010.
Giuliano AR, Lazcano-Ponce E, Villa LL, Flores R, Salmeron J, Lee JH, et al.: The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev 2008, 17:2036–2043.PubMedCrossRef
- Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
- Online Date
- January 2012
- Online ISSN
- BioMed Central
- Additional Links
- Genital warts
- Condylomata acuminata
- Industry Sectors
- Author Affiliations
- 1. Department of Epidemiology, Sanofi Pasteur MSD, Lyon, France
- 2. Department of Oral Radiology and Pathology, Faculty of Medicine, Institute of Dentistry and MediCity Research Laboratory, Turku, Finland
- 3. Cancer Epidemiology Research Program, L’Hospitalet de Llobregat, Institut Català d’Oncologia (ICO)-IDIBELL, Catalonia, Spain
- 4. CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain